PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.36%
Net income growth under 50% of CRON.TO's 121.24%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
0.01%
Less D&A growth vs. CRON.TO's 16.69%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-1681.60%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
18.09%
Less SBC growth vs. CRON.TO's 134.45%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-269.64%
Both reduce yoy usage, with CRON.TO at -79.28%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
87.09%
Some yoy increase while CRON.TO is negative at -3724.93%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-62.19%
Both yoy CFO lines are negative, with CRON.TO at -77.09%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
38.47%
Some CapEx rise while CRON.TO is negative at -75.99%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-355.81%
Negative yoy purchasing while CRON.TO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
No Data
No Data available this quarter, please select a different quarter.
55.42%
Growth well above CRON.TO's 100.00%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-10.75%
Both yoy lines negative, with CRON.TO at -23.27%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-73.48%
We cut debt repayment yoy while CRON.TO is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
10.97%
We slightly raise equity while CRON.TO is negative at -100.00%. John Neff sees competitor possibly preserving share count or buying back shares.
No Data
No Data available this quarter, please select a different quarter.